Detecting and quantifying p53 isoforms at mRNA level in cell lines and tissues

Methods in Molecular Biology

Volumn 962, Issue , 2013, Pages 1-14

  Khoury, Marie P ^a   Marcel, Virginie ^a   Fernandes, Kenneth ^a   Diot, Alexandra ^a   Lane, David P ^a   Bourdon, Jean Christophe ^a  

^a UNIVERSITY OF DUNDEE   (United Kingdom)

Author keywords

Cancer; Detection; mRNA; Nested PCR; p53 isoforms; p53 tumor suppressor protein; Quantification; Splicing

Indexed keywords

EID: 84871891032     PISSN: 10643745     EISSN: None     Source Type: Book Series    
DOI: 10.1007/978-1-62703-236-0_1     Document Type: Article

References (14)

1. Khoury MP, Bourdon J-C (2011) p53 iso-forms: an intracellular microprocessor? Genes Cancer 2:453-465
2. Bourdon J-C, Fernandes K, Murray-Zmijewski F, Liu G, Diot A, Xirodimas DP, Saville MK, Lane DP (2005) p53 isoforms can regulate p53 transcriptional activity. Genes Dev 19: 2122-2137
3. Ghosh A, Stewart D, Matlashewski G (2004) Regulation of human p53 activity and cell localization by alternative splicing. Mol Cell Biol 24:7987
4. Anensen N, Oyan AM, Bourdon JC, Kalland KH, Bruserud O, Gjertsen BT (2006) A distinct p53 protein isoform signature re flects the onset of induction chemotherapy for acute myeloid leukemia. Clin Cancer Res 12: 3985-3992
5. Boldrup L, Bourdon JC, Coates PJ, Sjostrom B, Nylander K (2007) Expression of p53 iso-forms in squamous cell carcinoma of the head and neck. Eur J Cancer 43:617-623
6. Avery-Kiejda KA, Zhang XD, Adams LJ, Scott RJ, Vojtesek B, Lane DP, Hersey P (2008) Small molecular weight variants of p53 are expressed in human melanoma cells and are induced by the DNA-damaging agent cisplatin. Clin Cancer Res 14:1659-1668
7. Marabese M, Marchini S, Marrazzo E, Mariani P, Cattaneo D, Fossati R, Compagnoni A, Signorelli M, Moll UM, Codegoni AM et al (2008) Expression levels of p53 and p73 iso-forms in stage I and stage III ovarian cancer. Eur J Cancer 44:131-141
8. Song W, Huo SW, Lu JJ, Liu Z, Fang XL, Jin XB, Yuan MZ (2009) Expression of p53 isoforms in renal cell carcinoma. Chin Med J (Engl) 122:921-926
9. Fujita K, Mondal AM, Horikawa I, Nguyen GH, Kumamoto K, Sohn JJ, Bowman ED, Mathe EA, Schetter AJ, Pine SR, Ji H, Vojtesek B, Bourdon J-C, Lane DP, Harris CC (2009) p53 isoforms Delta133p53 and p53beta are endogenous regulators of replicative cellular senescence. Nat Cell Biol 11:1135-1142
10. Khoury MP, Bourdon J-C (2010) The iso-forms of the p53 protein. Cold Spring Harb Perspect Biol 2:a000927
11. Marcel V, Vijayakumar V, Fernandez-Cuesta L, Hafsi H, Sagne C, Hautefeuille A, Olivier M, Hainaut P (2010) p53 regulates the transcription of its Delta133p53 isoform through specific response elements contained within the TP53 P2 internal promoter. Oncogene 29:2691-2700
12. Aoubala M, Murray-Zmijewski F, Khoury MP, Fernandes K, Perrier S, Bernard H, Prats AC, Lane DP, Bourdon J-C (2010) p53 directly transactivates D 133p53 a, regulating cell fate outcome in response to DNA damage. Cell Death Differ 18:248-258
13. Khoury MP, Bourdon J-C, Diot A, Baker L, Fernandes K, Aoubala M, Quinlan P, Purdie CA, Jordan LB, Prats AC, Lane DP, Thompson AM (2011) p53 mutant breast cancer patients expressing p53 g have as good a prognosis as wild-type p53 breast cancer patients. Breast Cancer Res 13(1):R7
14. Livak KJ, Schmittgen TD (2001) Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25:402-408